NeOnc Technologies Holdings is trading at $2.93, up 5.78%, as biotech-sector strength is the clearest available explanation; no company-specific cause is confirmed.
- Biotech ETF XBI is up 2.10% during the regular session.
- NeOnc announced an Abu Dhabi research and clinical-capability MoU on October 21, covering oncology and central nervous system therapeutics. It may contribute to investor interest, but available reporting does not establish that it caused the gain.